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ORIGINAL ARTICLE
Background/Aims: Maintenance dialysis is made decreased the death rate of patients with end-stage renal
disease; however, mortality is still high. The aim of this study was to identify the association between clinical
parameters at the start of hemodialysis with survival and compare these findings with data from patients who
underwent hemodialysis about 15 years ago at the same dialysis center.
Methods: We reviewed 117 patients who started hemodialysis between 2000 and 2004. We analyzed medical
histories, laboratory findings, and clinical outcomes, and compared them with patients who started hemodialysis
15 years ago at the same center.   
Results: The proportion of elderly patients and those with diabetes increased from 17% and 18% in the previous
study to 33% and 49% in this study, respectively. Elderly and patients with diabetes had much higher mortalities
than their counterparts. Nevertheless, the overall survival rate (66% vs. 71% at 5 years) and survival of patients
with diabetes improved (55% vs. 75% at 1.5 years). Common causes of death were infection and cardiovascular
disease in the present study; however, inadequate dialysis accounted for 25% of deaths in the previous study. 
Conclusions: The overall survival rate of patients undergoing hemodialysis has improved over the 15-year
interval, even with an increased proportion of elderly patients and patients with diabetes. Adequate dialysis and
further medical improvements could ameliorate mortality in patients undergoing dialysis. (Korean J Intern Med
2010;25:188-194)
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INTRODUCTION
Maintenance dialysis is made decreased the death rate
associated with end-stage renal disease (ESRD); however,
mortality remains high in patients on hemodialysis. Once
renal replacement therapy is initiated, the range of
expected life span according to the United States Renal
Data System report is approximately 8 years for patients
aged 40 to 44 undergoing dialysis and approximately 4.5
years for those 60 to 64 years of age [1]. The most common
cause of death is cardiovascular disease, and comorbid
conditions such as diabetes mellitus, ischemic heart disease
[1-4], inadequate dialysis [5,6], long duration on dialysis
[7], serum potassium level less than 4.0 or greater than
5.6 mEq/L [8], and malnourished state [6] are factors
known to be correlated with decreased survival. Survival
and quality of life in ESRD patients are expected to be
improved by determining the correctable factors associated
with inadequate dialysis and malnu-trition such as Kt/V,
body mass index, serum albumin, cholesterol, potassium,
and hemoglobin level. 
Over the past decade, a number of large-scale studiesSeok SJ, et al. Comparison of dialysis groups over time at a single center    189
have examined the impact of several factors at the
initiation of dialysis on the survival of individuals with
ESRD. However, little information is available on the
changes in survival patterns among Asian patients with
ESRD over time.
Therefore, the aim of this study was to identify asso-
ciations between clinical parameters at the initiation of
hemodialysis with survival by assessing these parameters
in patients who began dialysis at Soonchunhyang
Cheonan Hospital from January 2000 to January 2004
and comparing the results with data from patients who
underwent hemodialysis about 15 years ago at the same
dialysis center.
METHODS
Materials
The medical records of patients with ESRD who began
dialysis at Soonchunhyang Cheonan Hospital from
January 2000 to January 2004 were reviewed retro-
spectively. Among these patients, those without complete
medical records were excluded. Additionally, patients
who had died within 3 months after starting hemodialysis
were excluded. Finally, 117 patients were enrolled in this
study. 
We compared our findings with those of a previous
retrospective study [9]. The previous study included 109
patients who underwent hemodialysis about 15 years
ago (from June 1984 to December 1990) at the same
dialysis center.
Methods
We retrospectively reviewed the medical records and
laboratory findings at the beginning of hemodialysis. The
patient characteristics included age, gender, cigarette
smoking, body mass index, comorbid conditions at the
time of initiating hemodialysis (diabetes mellitus,
hypertension, ischemic heart disease, congestive heart
failure, left ventricular hypertrophy, cerebrovascular
accident, and chronic liver disease), number of antihy-
pertensive medications (angiotensin-converting enzyme
inhibitor/angiotensin II receptor blockers, calcium
channel blockers, beta-blockers, minoxidil, and diuretics,
which were regarded as one class of antihypertensives
each), biochemical markers (blood urea nitrogen,
creatinine, calcium, phosphorus, sodium, potassium, uric
acid, albumin, total cholesterol), arterial blood gases,
hemoglobin, hematocrit, leukocyte, and platelet counts.
The vascular access method for the first hemodialysis was
classified as arteriovenous fistula/graft, jugular venous
catheter, subclavian catheter, femoral catheter, or tunneled
catheter. Furthermore, we recorded patient survival based
on the survival duration up to April 30, 2009, including
the observation period to death, cause of death, and
morbidity during the follow-up period.
The patients who were transferred to local dialysis
facilities were followed by questionnaires sent to the
facilities, and information on survival, date of death, and
cause of death were recorded. If the data were not available
from the facilities, they were obtained from the ESRD
Registry Committee of the Korean Society of Nephrology.
Statistical analysis
Data are presented as the mean ± standard deviation for
continuous variables and as frequencies (percent) for
categorical variables. Statistical analyses were performed
using SPSS version 14.0 (SPSS Inc., Chicago, IL, USA),
and all p values < 0.05 were considered statistically
significant. The differences between groups were compared
with the Student’s t test or analysis of variance (ANOVA)
for continuous variables and by the χ2 test or Fisher’s
exact test for categorical variables. The dependence between
variables was analyzed using a bivariate correlation analysis.
Multiple logistic regression analyses were used to determine
the factors affecting survival duration after the initiation of
hemodialysis. The results of the logistic regression
analyses were recorded as odds ratios with 95% confidence
intervals. The Kaplan-Meier analysis was used to compare
the survival rate between groups. The survival duration
was measured from the start of hemodialysis to death or
to April 30, 2009.
RESULTS
Baseline patient characteristics 
The most common renal disease leading to ESRD was
diabetes mellitus (48.7%), followed by hypertension,
chronic glomerulonephritis, and polycystic kidney disease. 
The method of vascular access for the first hemodialysis
was arteriovenous fistula/graft (31.6%), jugular venous
catheter (47.3%), subclavian catheter (16.7%), femoral
catheter (0.9%), and tunneled catheter (3.5%). 
The numbers of antihypertensive medications used
before the initiation of hemodialysis were 0 (11.8%), 1190 The Korean Journal of Internal Medicine Vol. 25, No. 2, June 2010
(28.8%), 2 (28.8%), 3 (18.9%), 4 (10.8%), and 5 (0.9%).
Patients were most commonly taking calcium channel
blockers (53.0%), followed by angiotensin-converting
enzyme inhibitor/angiotensin II receptor blockers
(49.6%), diuretics (42.7%), beta-blockers (31.6%), and
minoxidil (3.4%).
Most patients had anemia (91.9%, hemoglobin level <
11.0 g/dL) and metabolic acidosis (77.4%, bicarbonate
level less than 20 mEq/L) at the initiation of hemodialysis.
Risk factors affecting patient survival
The causes of death were infection (43.8%), cardio-
vascular disease (21.9%), and cerebrovascular accident
(9.4%). However, those of a previous study reported in
1992  [9] were cerebrovascular accident (32.1%) and
discontinuation of dialysis (25.0%). 
Patients who died demonstrated higher average age
(48.9 ± 13.0 vs. 57.3 ± 9.4 years, p = 0.001), increased
leukocyte count (7,101.8 ± 2,369.4 vs. 8,647.5 ± 4,438.9 /L,
p = 0.050), and decreased platelet (190.7 ± 81.9 vs. 235.9
± 112.9 × 103 /µL, p = 0.025) and creatinine levels (9.3 ±
4.4 vs. 6.8 ± 2.9 mg/dL, p = 0.002). However, there was
no difference in survival associated to gender, initial body
mass index, blood urea nitrogen, serum albumin, total
cholesterol, ferritin level, hemoglobin, or hematocrit.
A logistic regression analysis was performed for comorbid
conditions as predictors of mortality. Diabetes, ischemic
heart diseases, and left ventricular hypertrophy were
related to increased mortality rate. However, only diabetes
(p = 0.019) and left ventricular hypertrophy (p = 0.035)
were statistically significant in the multivariate logistic
regression analysis. Other factors such as cigarette
smoking, cerebrovascular accidents, liver disease, the
method of vascular access for the first hemodialysis, and
the number of antihypertensive medications were not
significantly different between the survivors and the
patients who died.
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Figure 1. Comparison of survival rates between our study and a
previous study at the same center in 1992. (A) Overall 5-year
survival was 66% in the previous study vs. 71% in this study. (B)
The percentage of surviving patients with diabetes was 64% in the
previous study vs. 86% in this study at 1 year and 55% vs. 61% at 3
years. (C) The percentage of surviving nondiabetic patients was
84% in the previous study vs. 98% in this study at 1 year, and 77%
vs. 95% at 3 years.Seok SJ, et al. Comparison of dialysis groups over time at a single center    191
Patient survival by underlying renal disease and
age
After censoring at the time of death, 94 patients were
available to evaluate survival duration at a mean follow-up
of 68.3 ± 32.7 months (range, 4 to 111).
No significant differences were found in survival
duration of the patients who had died according the
method of vascular access for the first hemodialysis (p =
0.247) or the number of antihypertensive medications
taken (p= 0.739). 
Renal diseases leading to ESRD were classified as
diabetic versus nondiabetic and analyzed by the Kaplan-
Meier method. The cumulative survival rates were 95%,
92%, and 87% in the nondiabetic group, and 83%, 62%,
and 55% in the diabetic group at 1, 3, and 5 years,
respectively (Fig. 1). The mean survival duration (diabetes
mellitus, 25.2 ± 21.9 months; hypertension, 55.6 ± 13.5
months; polycystic kidney disease, 17.7 ± 17.2 months;
one-way ANOVA, p = 0.014) and cumulative survival
rates according to each underlying renal disease demon-
strated statistically significant differences. The cumulative
survival rates at 1 year were 74% in patients with diabetes
mellitus, 75% in those with polycystic kidney disease, and
100% in those with hypertension and chronic glomeru-
lonephritis. At 3 years they were 60%, 63%, and 100%,
and at 5 years they were and 55%, 63%, 90%, respectively.
According to the age at the start of hemodialysis, patients
were classified as less than 30 years of age, 31 to 60 years,
or over 60 years of age. The cumulative survival rates at 1
year were 100% in patients less than 30 years of age, 93%
in those 31 to 60 years, and 86% in those over 60 years of
age. The cumulative survival rates at 3 years were 100%,
83%, and 69%; at 5 years, they were 100%, 76%, and 55%;
and at 7 years, they were 50%, 39%, 24%, respectively
(Fig. 2). Older patients (p = 0.001) and patients with
diabetes (p = 0.001) had a much higher mortality rate
than their counterparts.
Additionally, patients were classified into four groups
according to whether they had diabetes and their age at
the start of hemodialysis. The cumulative survival rates in
the group with diabetes and over 60 years of age were
36% at 3 years and 28% at 7 years, which were much
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Figure 2. Comparison of survival rates according to age at the
start of hemodialysis between our study and the previous study in
1992. (A) The percentage of surviving patients less than 30 years
of age was 88% in the previous study vs. 100% in this study at 3
years. (B) The percentage of surviving patients between 31 and 60
years of age was 81% in the previous study vs. 93% in this study at
1 year and 69% vs. 83% at 3 years. (C) The percentage of surviving
patients over 60 years of age was 72% in the previous study vs.
86% in this study at 1 year and 58% vs. 69% at 3 years.192 The Korean Journal of Internal Medicine Vol. 25, No. 2, June 2010
lower than the 97% survival rate at 3 years and 93% at 7
years in the group without diabetes and who were less
than 60 years of age.
DISCUSSION
Maintenance dialysis has decreased the death rate
associated with ESRD; however, the mortality in patients
on hemodialysis remains high. The ESRD Registry
Committee of the Korean Society of Nephrology reported
that, among patients on hemodialysis, the cumulative
survival rates were 94%, 83%, and 73% in nondiabetic
patients, and 93%, 70%, and 53% in patients with diabetes
at 1, 3, and 5 years, respectively [10]. In comparison, in the
present study, the nondiabetic group had higher and the
diabetic group had lower survival rates (95%, 92%, and
87% in nondiabetic group; 83%, 62%, and 55% in the
diabetic group at 1, 3, and 5 years, respectively). The
finding for diabetic patients was consistent with the
findings of previous studies and the USRDS data [1]. This
result suggests that diabetes mellitus at the initiation of
hemodialysis is a predictor of increased mortality.
Our center is located in a rural town and has been in
operation since 1984. It may be important to analyze
survival at a single center to maintain the quality of
hemodialysis. In a previous study of 109 patients who
underwent dialysis from June 1984 to December 1990 at
the same center, the cumulative survival rates were 81% at
1 year and 66% at 5 years [9] compared to 95% and 86%
in this study. These findings suggest that the overall
survival rates have improved over the 15-year interval, as
both studies were conducted at the same center and in
the same region. However, the proportion of patients over
60 years of age undergoing hemodialysis increased from
17% in the previous study reported in 1992 to 33% in the
present study. Moreover, the most common underlying
renal disease has changed from chronic glomerulonephritis
(36%) to diabetes mellitus (49%). Consequently, the
proportion of patients with diabetes as a cause of ESRD
has increased from 18% to 49% over the 15-year interval.
The earlier study reported that diabetes mellitus was a
predictor of poorer outcome, with a cumulative survival
rate of patients with diabetes of 55% at 1.5 years [9].
However, the patients with diabetes in this study
demonstrated improved cumulative survival rates (83% at
1 year and 55% at 5 years, Fig. 1). Therefore, the overall
survival rate of hemodialysis patients has improved over
the past 15 years even with the increased proportion of
elderly patients (17% vs. 33% over 60 years of age) and of
those with diabetes mellitus (18% vs. 49%, Fig. 3). The
reasons for improved survival might be the increased
proportion of patients undergoing adequate dialysis due
to improved quality management and the remarkable
progress of medical science, as well as improved instru-
mentation, dialysis membranes, dialysates, and the
quality of water [11,12]. In fact, dialysis membranes used
in the previous study were the GC-150M (cuprammonium
rayon; surface area, 1.0 m2; ultrafiltr ation rate [UFR],
4.0 mL/Hg.h) and CF Model 12.11 (cuprophan; surface
area, 0.8 m2; UFR, 4.0 mL/Hg.h) [9] with surface areas
no more than 1.0 m2. In the present study, the dialysis
membranes were Polyamix™‚ (polyarylethersulfone,
polyvinylpyrrolidone, polyamide blend; surface area, 1.7 to
2.1 m2; ultrafiltration coefficient, 70 to 85 mL/h.mmHg)
and Helixone® (polysulfone high flux; surface area, 1.4 to
1.8 m2; ultrafiltration coefficient 46 to 59 mL/h.mmHg)
with surface areas more than 1.4 m2. Moreover, the
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Figure 3. (A) The causes of end stage renal disease in the present study demonstrated a much higher frequency of diabetes mellitus
compared to the previous study in 1992. (B) The age distribution showed an increased proportion of elderly patients.Seok SJ, et al. Comparison of dialysis groups over time at a single center    193
previous study had no standard definition for “adequate
dialysis,” and most patients underwent hemodialysis twice
per week. Furthermore, many patients could not continue
dialysis or increase dialysis frequency due to the economic
burden, even though their uremic condition was aggravated.
Consequently, inadequate dialysis accounted for up to
25% of deaths reported in the previous study. Currently,
we maintain dialysis quality by monitoring the Kt/V
regularly, and most patients continue dialysis without
excessive economic problems. 
Over the past decade, a number of large-scale studies
have analyzed the survival rate of elderly patients with
ESRD [13,14]. In this study, elderly patients with ESRD
had much higher mortality rates than did younger patients;
the mortality rates at 5 years were 0.0% in patients less
than 30 years of age, 23.7% in those between 31 and 60
years, and 44.8% in those over 60 years of age (p= 0.008).
Therefore, close observation and management are needed
in patients starting dialysis who are over 60 years of age.
The cumulative survival rates revealed an association
between dialysis duration and increased risk of death:
95% survival at 1 year of dialysis, 90% at 3 years, 86% at 5
years, 72% at 6 years, and 57% at 7 years of dialysis. These
results suggest that increased age, diabetes mellitus, and
increased length of time on dialysis were significant risk
factors for death.
Previous studies have reported inadequate dialysis, long
dialysis duration, and serum potassium levels less than
4.0 or greater than 5.6 mEq/L [5-8] as predictors for
increased mortality. Comorbid conditions such as diabetes
mellitus, ischemic heart disease [1-4,15], late referral to
nephrologists [16], and malnourished state [6,15],
particularly a serum albumin level less than 3.0 g/dL and
lower body mass index [6,17], are factors correlated with
morbidity and decreased survival. We found no significant
differences in survival according to the initial body mass
index, serum albumin, total cholesterol, potassium level,
and hematocrit. However, the serum albumin levels were
low in both groups (3.2 ± 0.6 g/dL in the survivors, 3.0 ±
0.5 g/dL in the patients who died) suggesting that
malnutrition was already advanced at the beginning of
hemodialysis. In the group of patients who died, the
leukocyte count increased and creatinine decreased,
consistent with previous reports, indicating that chronic
inflammation and malnutrition are associated with
decreased survival [18]. Therefore, early dialysis manage-
ment is needed before patients develop malnutrition and
chronic inflam-mation.
Comorbid conditions such as ischemic heart disease
and left ventricular hypertrophy were associated with an
increased risk of death, consistent with the findings of a
previous study [19]. Therefore, screening for cardiovascular
disease is needed in this group of patients.
Unlike the findings reported in other studies [1,10], the
most common cause of death was infections (43.8%),
followed by cardiovascular disease (21.9%) and cerebrovas-
cular accidents (9.4%). This result was different from the
data in the ESRD Registry Committee of Korean Society of
Nephrology, which reported, in order, cardiologic origin
(31.7%), vascular origin (17.8%), and infectious origin
(20.2%) [10] as the most common causes of death. These
differences are likely due to data management and the
censoring of data. We obtained data from the ESRD
Registry Committee of the Korean Society of Nephrology,
but information was missing as well. Only 59.3% of all 535
dialysis centers were available to provide data. Therefore,
unified registries of the data on patients with ESRD must
improve, just the management of them does.
In conclusion, the overall survival rate of patients
undergoing hemodialysis has improved over the past 15
years, even with the increased proportion of elderly patients
and those with diabetes mellitus in the current group.
Compared with patients 15 years ago, improvements in
dialysis membranes, adequacy of dialysis, and medical
science appear to have ameliorated mortality in patients
under-going dialysis.
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